AnaptysBio Inc. (ANAB)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) 
$
46. 61
-2.1
-4.3112%
$
2.99B Market Cap
- P/E Ratio
- Div Yield
413,635 Volume
-6.06 Eps
$ 48.71
Previous Close 
Want to track ANAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AnaptysBio Inc. (ANAB) Statistics
Valuation metrics
Market Cap 2.99B
Enterprise value 1.5B
Trailing P/E (ttm) 6.81
Forward P/E -14.65
PEG ratio -0
Price/Sales (ttm) 5.73
Price/Book (mrq) 127.04
Enterprise Value/Revenue 6.3
Enterprise Value/EBITDA 16.28
Overview
Shares outstanding 28.02M
Float 17.26M
Shares short 4.81M
% Held by insiders 0.06%
% Held by institutions 1.01%
Average volume (10 days) 503.75K
Average volume (90 days) 506.37K
Price summary
52-Week low 20.18
52-Week high 72.36
Beta 0.41
50-Day moving average 52.11
200-Day moving average 54.83
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 15:10
Last split Date 20 Apr 2026
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.82%
Operating margin 0.56%
Operational effectiveness
Return on assets 0.62%
Return on equity 25.15%
Income Statement
Revenue (ttm) 234.6M
Revenue per share (ttm) 8.12
Quarterly revenue growth (yoy) 1.51%
Gross profit (ttm) 98.63M
EBITDA 69.25M
Net income to common (ttm) -13.23M
Diluted EPS (ttm) 6.69
Quarterly earnings growth (yoy) 1.51%
Balance Sheet
Total cash (mrq) 311.64M
Total cash per share (mrq) 5.61
Total debt (mrq) 290.64M
Total Debt/Equity (mrq) 25.47
Current ratio (mrq) 5.61%
Book value per share (mrq) 0.36
Cash Flow
Cash flow statement 19.7M
Levered free cash flow (LFCF) 19.34M
2026 © Marketlog. All Rights Reserved.
